These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1877328)

  • 1. [Administration of prostaglandin E1 in diabetics and non-diabetic patients with severe Fontaine stage IIb arterial occlusive disease].
    Hinderer S; Brachmann R; Nedder KH; Bucher J; Beischer W
    Vasa; 1991; 20(2):100-8. PubMed ID: 1877328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of intra-arterial and intravenous prostaglandin E1 infusions in occlusive arterial disease stage III/IV.
    Balzer K; Rogatti W; Rüttgerodt K
    Vasa Suppl; 1989; 28():31-8. PubMed ID: 2609242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
    Rudofsky G
    Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Placebo controlled, double-blind study of the effectiveness of i.v. prostaglandin E1 in diabetic patients with stage IV arterial occlusive disease].
    Stiegler H; Diehm C; Grom E; Martin M; Mörl H; Rudofsky G; Vogelberg KH
    Vasa Suppl; 1992; 35():164-6. PubMed ID: 1481031
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
    Altstaedt HO; Berzewski B; Breddin HK; Brockhaus W; Bruhn HD; Cachovan M; Diehm C; Dörrler J; Franke CS; Gruss JD
    Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Randomized study comparing the clinical effectiveness of intravenous prostaglandin E1 and intravenous pentoxifylline in patients with Fontaine stage IIb arterial occlusive disease].
    Hepp W; von Bary S; Corovic D; Diehm C; Mühe E; Rudofsky G; Scheffler P; Trübestein G; Vogelpohl M
    Vasa Suppl; 1991; 33():348-9. PubMed ID: 1788753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
    Creutzig A; Caspary L; Alexander K
    Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial and intravenous administration of prostaglandin E1 cause different changes to skin microcirculation in patients with peripheral arterial occlusive disease.
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa; 1998 May; 27(2):100-5. PubMed ID: 9612114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
    Thum J; Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and haemostatic effects of intravenous prostaglandin E1 therapy in patients with peripheral arterial occlusive disease.
    Trifiletti A; Scamardi R; Pizzoleo MA; Sottilotta G; Soraci S; Attinà A; Bagnato L; Barbera N
    Panminerva Med; 1999 Mar; 41(1):15-7. PubMed ID: 10230250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of intravenously applied prostaglandin E1.
    Scheffler P; de la Hamette D; Leipnitz G
    Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterial prostaglandine E1 in arterial occlusive disease (AOD) stages III and IV.
    Herold A; Bruch HP; Hörl M; Düsel W
    Prog Clin Biol Res; 1987; 242():439-44. PubMed ID: 2959966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous administration of PGE1: studies of the effectiveness and duration of the effect of various dosages based on flow measurements of the femoral artery in patients with healthy vessels and in stage IIb arterial occlusive disease].
    Scheffler P; Birkel L; Grub KR; de la Hamette D
    Vasa Suppl; 1988; 23():126-9. PubMed ID: 3061035
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcutaneous oxygen pressure as predictive parameter for ulcer healing in endstage vascular patients treated with spinal cord stimulation.
    Claeys LG; Horsch S
    Int Angiol; 1996 Dec; 15(4):344-9. PubMed ID: 9127776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pilot study of the effect of intravenous prostavasin therapy of inpatients with diabetes mellitus and IIb arterial occlusive disease].
    Rosak C; Hofmann U; König P; Nitsche GB
    Vasa Suppl; 1991; 33():339-40. PubMed ID: 1788748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of intra-arterial and intravenous PGE1 infusions on transcutaneous oxygen pressure in patients with critical ischemia of the extremities].
    Weiss T; Griesshaber J; Rogatti W; Kistner O; Hsu E; Jansen T; Diehm C
    Vasa Suppl; 1991; 33():341-2. PubMed ID: 1788749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
    Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
    Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
    Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
    Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous prostaglandin E1 versus pentoxifylline therapy in chronic arterial occlusive disease--a controlled randomised multicenter study.
    Trübestein G; von Bary S; Breddin K; Diehm C; Gruss JD; Heinrich H; Horsch S; Kriessmann A; Maass U; Martin M
    Vasa Suppl; 1989; 28():44-9. PubMed ID: 2692200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.